drugset / Trial / NCT00504153
Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This phase II trial is studying dasatinib to see how well it works in treating patients with previously treated metastatic colorectal cancer. Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for their growth.
Timeline
- Start
- 2007-07
- Primary completion
- 2011-06
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | dasatinib anhydrous | Small molecule | — | Oral |